Komen breast cancer charity cancels walks in seven U.S. cities
By Lisa Maria Garza DALLAS (Reuters) - Breast cancer charity Susan G. Komen for the Cure, which suffered a publicity backlash last y...
Read More »
By Lisa Maria Garza DALLAS (Reuters) - Breast cancer charity Susan G. Komen for the Cure, which suffered a publicity backlash last y...
Read More »(Reuters) - Aveo Pharmaceuticals Inc said it would cut about 62 percent of its workforce, or 140 jobs, to focus on developing its mo...
Read More »By Soyoung Kim and Greg Roumeliotis NEW YORK (Reuters) - Private equity firms KKR & Co LP, Warburg Pincus LLC and Cinven Ltd are wei...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Despite the U.S. government offering hefty financial incentives to doctors for using...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Cholesterol-lowering drugs could be tied to more muscle problems than researchers pre...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - The proportion of middle-aged American men being treated for low testosterone more th...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - Men taking drugs in the fluoroquinolone family were twice as likely to suffer serious k...
Read More »
By Sarah McBride SAN FRANCISCO (Reuters) - Microsoft co-founder Bill Gates is leading a $35 million investment in ResearchGate, a Be...
Read More »
By David Morgan WASHINGTON (Reuters) - U.S. Health and Human Services Secretary Kathleen Sebelius said on Tuesday that she talked to...
Read More »(This is a corrected version of a December 20, 2012 story that was erroneously issued on June 3, 2013 without the correction informa...
Read More »